Mineralys Therapeutics In... (MLYS)
undefined
undefined%
At close: undefined
11.90
0.59%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20
Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Income -84.66M -31.48M -18.73M -2.94M
Interest Income 12.76M 1.68M - -
Pretax Income -71.90M -29.80M -19.41M -3.43M
Net Income -71.90M -29.80M -19.41M -3.43M
Selling & General & Admin 14.30M 5.23M 2.42M 532.00K
Research & Development 70.36M 26.25M 16.31M 2.41M
Other Expenses - 4.00K 1K -1K
Operating Expenses 84.66M 31.48M 18.73M 2.94M
Interest Expense - 1.68M 27.00K 115.00K
Selling & Marketing Expenses - - - -
Cost & Expenses 84.66M 31.48M 18.73M 2.94M
Income Tax - -1.90M 27.00K 115.00K
Shares Outstanding (Basic) 36.19M 40.86M 39.06M 39.06M
Shares Outstanding (Diluted) 36.19M 40.86M 39.06M 39.06M
EPS (Basic) -1.99 -0.73 -0.5 -0.09
EPS (Diluted) -1.99 -0.73 -0.5 -0.09
EBITDA -84.66M -31.48M - -
Depreciation & Amortization - 228.49K 18.73M 2.94M